Novo Nordisk

Pharma

FDA approves Lilly's Mounjaro to reduce risk of cardio events

The FDA has signed off on a label expansion for Eli Lilly's Mounjaro to reduce the risk of heart attack or stroke in at-risk adults with type 2 diabetes.

Kevin Dunleavy Aug 28, 2026 10:52am

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K

Aug 28, 2026 9:30am

Novo testing smaller doses of Wegovy pill in phase 3 study

Aug 20, 2026 8:51am

Danish politicians call out Lilly campaign

Aug 16, 2026 8:25am

Obesity not a winner-takes-all game, Novo CEO says: Reuters

Aug 13, 2026 11:33am

Of biopharma's top 25 companies, 9 had double-digit sales bumps

Aug 12, 2026 11:47am